Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (2428)	4/12/2005 7:25:50 PM
From: tuck	Respond to of 2515

>>This should create a buying op for those that want one.<< Good for a nearly 5% trimming after hours. Cheers, Tuck

To: tuck who wrote (2428)	5/12/2005 9:29:55 AM
From: tom pope	Respond to of 2515

And now this: Imclone discontinue Small Molecule Program 2005-05-12 07:43:47 33.47: Co filed 8-K disclosing that on May 11 it's Board of Directors committed to a plan to discontinue the Co's small molecule program. This action was taken after completion of an evaluation of the research being conducted within the small molecule group, and took into account the time horizon before commercial benefits would be realized. The Company expects this plan to be completed by the middle of July 2005. In connection with discontinuing the small molecule program, IMCL will incur pre-tax charges of approx $2 mln in Q2 of 2005 associated with one-time termination benefits. In addition, Co is analyzing its options with respect to the disposition of the long-lived assets used by this group, which as of April 30, 2005 amounted to approx $5.5 mln.